Advancements in hepatocellular carcinoma

Area of Science:

• Hepatobiliary Medicine
• Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) remains a significant global health challenge.
• Early detection and effective management are crucial for improving patient outcomes.

Purpose of the Study:

• To review recent advancements in the prevention and treatment of hepatocellular carcinoma.
• To highlight emerging therapeutic strategies and prognostic tools.

Main Methods:

• Literature review of recent studies on hepatocellular carcinoma management.
• Analysis of new developments in molecular markers, staging systems, and treatment modalities.

Main Results:

• Promising molecular markers for tumor biology are under development.
• The Barcelona Clinic Liver Cancer (BCLC) staging system provides key prognostic information.
• While surgery is standard, percutaneous ablation and chemoembolization show effectiveness with improved survival in selected patients.

Conclusions:

• Evolving management strategies for hepatocellular carcinoma are essential.
• Focused therapies and improved adjuvants are needed for better pre- and post-transplant outcomes.
• A clearer understanding of HCC pathogenesis fuels hope for enhanced disease control.